MUSTANG BIO INC (MBIO) Stock Balance Sheet
NASDAQ:MBIO - Nasdaq - US62818Q3020 - Common Stock - Currency: USD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 6.23M | 75.70M | 109.60M | 97.80M | 61.40M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | 0.00 | |||
| Receivables | 3.88M | 0.00 | 100.00K | 0.00 | 0.00 | |||
| Other Current Assets | 1.23M | 3.20M | 2.00M | 1.70M | 1.60M | |||
| Total Current Assets | 11.35M | 78.90M | 111.70M | 99.50M | 63.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.81M | 12.30M | 12.10M | 9.10M | 9.10M | |||
| Other Non-Current Assets | 1.58M | 1.30M | 1.40M | 1.30M | 1.30M | |||
| Total Non-Current Assets | 6.40M | 13.50M | 13.50M | 10.40M | 10.30M | |||
| TOTAL ASSETS | 17.74M | 92.40M | 125.20M | 109.90M | 73.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 0.00 | 1.30M | |||
| Accrued Expenses | 8.31M | 7.60M | 6.70M | 5.60M | 4.10M | |||
| Accounts Payable | 6.32M | 6.80M | 3.50M | 3.50M | 1.90M | |||
| Other Current Liabilities | 739.00K | 600.00K | 600.00K | 400.00K | 500.00K | |||
| Total Current Liabilities | 15.37M | 15.10M | 10.80M | 9.50M | 7.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 27.40M | 0.00 | 0.00 | 12.20M | |||
| Other Non-Current Liabilities | 2.25M | 3.60M | 2.00M | 2.00M | 1.80M | |||
| Total Non-Current Liabilities | 2.25M | 31.00M | 2.00M | 2.00M | 14.00M | |||
| TOTAL LIABILITIES | 17.62M | 46.10M | 12.80M | 11.50M | 21.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -380.97M | -329.40M | -251.80M | -185.50M | -125.50M | |||
| Additional Paid In Capital | 380.50M | 374.50M | 359.90M | 276.00M | 172.20M | |||
| Common Shares | 592.00K | 1.10M | 4.30M | 7.90M | 4.90M | |||
| Other Shareholders' Equity | N/A | N/A | 0.00 | 0.00 | N/A | |||
| Shares Outstanding | 9.64M | 7.90M | 7.10M | 5.60M | 3.50M | |||
| Tangible Book Value per Share | 0.01 | 5.86 | 15.83 | 17.57 | 14.77 | |||
| Total Shareholders' Equity | 123.00K | 46.30M | 112.40M | 98.40M | 51.70M | |||
| TOTAL LIABILITIES AND EQUITY | 17.74M | 92.40M | 125.20M | 109.90M | 73.40M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.59 | N/A | N/A | 0.24 | |||
| Current Ratio | 0.74 | 5.23 | 10.34 | 10.47 | 8.09 | |||
| Return On Assets (ROA) | -290.85% | -83.91% | -53.01% | -54.61% | -63.20% | |||
| Return On Equity (ROE) | -41952.85% | -167.45% | -59.05% | -61.00% | -89.73% | |||
All data in USD , ROIC based on taxRate of 0.21